Editorial Views  |   February 2008
Ultrasound-guided Regional Anesthesia and the Prevention of Neurologic Injury: Fact or Fiction?
Author Notes
  • Department of Anesthesiology, Mayo Clinic, Rochester, Minnesota.
Article Information
Editorial Views / Central and Peripheral Nervous Systems / Radiological and Other Imaging / Regional Anesthesia / Trauma / Burn Care
Editorial Views   |   February 2008
Ultrasound-guided Regional Anesthesia and the Prevention of Neurologic Injury: Fact or Fiction?
Anesthesiology 2 2008, Vol.108, 186-188. doi:10.1097/01.anes.0000299835.04104.02
Anesthesiology 2 2008, Vol.108, 186-188. doi:10.1097/01.anes.0000299835.04104.02
PERIOPERATIVE nerve injuries have long been recognized as potentially devastating complications of regional anesthesia. A recent review of the published literature estimates that neurologic complications may occur in up to 3% of patients undergoing peripheral nerve blockade and in 0.4% of patients after neuraxial techniques.1 Fortunately, the number of these complications progressing to severe or disabling injury is extremely low. In fact, it has been estimated that 1 in 14,000 patients will develop a severe neurologic injury after spinal or epidural anesthesia.2 Despite these encouraging results, the potential for devastating sequelae will always be a concern for both patients and providers. In this issue of Anesthesiology, Koff et al.  3 further accentuate these concerns by presenting a case of severe brachial plexopathy after an ultrasound-guided interscalene block in a patient with multiple sclerosis (MS). The case is unique in that it highlights several important factors that should be considered by clinicians when evaluating patients and assessing the risk of regional anesthetic techniques. Important considerations include identifying potential contributors to perioperative nerve injury, understanding the importance of preexisting neurologic deficits, and recognizing the limitations of ultrasound-guided technology in preventing neurologic injury.
Perioperative nerve injury is a complex phenomenon that can be caused by a multitude of clinical factors. Patient, surgical, and anesthetic risk factors have all been identified as potential contributors to postoperative neurologic dysfunction. The case presented by Koff et al.  likely represents a clinical scenario in which several patient, surgical, and anesthetic variables contributed to an adverse neurologic event. It is unlikely that a single identifiable agent was the definitive cause of injury. In fact, a review of the American Society of Anesthesiologists Closed Claims database suggests that despite intensive medicolegal investigation, the cause of postoperative neurologic injuries is rarely identified.4 
Patient Risk Factors
Patient risk factors most commonly associated with perioperative nerve injury include male sex, increasing age, extremes of body habitus, and preexisting diabetes mellitus.5 However, it has been suggested that patients with preexisting neurologic deficits may be at increased risk as well. The patient presented in the case report by Koff et al.  was an elderly man with preexisting MS. The presence of chronic, underlying neural compromise secondary to mechanical, ischemic, toxic, metabolic, or in this case demyelinating conditions may theoretically place these patients at increased risk of further neurologic injury.6,7 As described by Koff et al.  , the “double-crush” phenomenon suggests that patients with preexisting neural compromise may be more susceptible to injury at another site when exposed to a secondary injury.7 Secondary injuries may include a variety of concomitant patient, surgical, or anesthetic risk factors.
Many clinicians are unaware that subclinical neural compromise may be present within the peripheral nervous system of patients with MS.8,9 In fact, subclinical sensorimotor deficits have been identified in 45%9 to 74%8 of MS patients, with up to 43% having abnormalities in more than one peripheral nerve distribution. This often ignored or poorly recognized phenomenon has been appropriately highlighted by Koff et al.  The authors emphasize the need for clinicians to consider these and other factors when evaluating MS patients for peripheral nerve blockade. Unfortunately, neural compromise may be present within the peripheral nervous system in the absence of clinical signs or symptoms and does not seem to be correlated with patient age, disease onset, or progression of the disease course. This lack of clinical correlation presents a unique challenge to anesthesia providers when evaluating MS patients for peripheral regional techniques.
Surgical Risk Factors
Surgical risk factors associated with perioperative nerve injury include direct intraoperative trauma or stretch, vascular compromise, perioperative infection or inflammation, hematoma formation, tourniquet ischemia, or improperly applied immobilizers or casts. Surgical variables may be the primary etiology of postoperative neurologic deficits in up to 88% of cases.10 One of the most important surgical risk factors may be the surgical procedure itself. Koff et al.  briefly alluded to the fact that the surgical procedure may have been a contributing factor in the development of the patient's severe brachial plexopathy. Total shoulder arthroplasty may be associated with postoperative neurologic deficits in up to 4.3% of cases—regardless of anesthetic technique—with the majority of injuries being localized to the upper trunks of the brachial plexus.11 
Anesthetic Risk Factors
Regional anesthetic factors that may contribute directly or indirectly to perioperative nerve injury include needle- or catheter-induced mechanical trauma, ischemic nerve injury secondary to vasoconstrictors or neural edema, and chemical injury from direct local anesthetic neurotoxicity.12 Several authors have investigated the role of mechanical trauma, including the role of needle gauge, type, and bevel configuration on peripheral nerve injury. The disruption of perineural tissue around nerve fascicles compromises the blood–nerve barrier and results in the herniation of endoneurial contents (i.e.  , myelinated nerve fibers) into the perineural space. However, needle-to-nerve contact by itself—in the absence of local anesthetic injection—rarely produces clinical or functional abnormalities. Rather, it is the combined effect of needle penetration and injection of local anesthetic into the neural fascicle that causes axonal degeneration and subsequent neurologic injury.12 
Limitations of Ultrasound-guided Regional Anesthesia
Finally, the ability of ultrasound-guided regional anesthesia to become the “holy grail” of regional anesthesia—providing neural blockade with rapid onset, long duration, and improved success, without complications—has recently been discussed.13 Although many advocates of ultrasound theorize that direct visualization of neural targets and needle advancement may decrease the frequency (and severity) of neurologic injury, preliminary results do not support the hypothesis that ultrasound guidance decreases the risk of neurologic complications.13 This should not be surprising if we consider the risk factors associated with neurologic injury and the ability (or lack thereof) of ultrasound in preventing these risk factors from making a clinical impact. For example, clearly the use of ultrasound guidance will have no impact on patient risk factors associated with nerve injury. The patient described by Koff et al.  will have the associated risk factors of male sex, increasing age, and a preexisting neurologic deficit regardless of anesthetic technique. Similarly, the use of ultrasound guidance will have no effect on surgical factors. Patients undergoing total shoulder arthroplasty will still be at risk of intraoperative trauma or stretch to the brachial plexus, hematoma formation, and perioperative inflammation. However, it is not unreasonable to presume that ultrasound may have a positive impact on anesthetic risk factors—albeit small. Of the anesthetic risk factors involved in perioperative nerve injury (mechanical trauma, neural ischemia, and local anesthetic toxicity), ultrasound guidance may be able to modify one, or at most two contributing factors, namely, mechanical trauma and local anesthetic neurotoxicity.
The ability of ultrasound guidance to avoid needle-to-nerve contact and mechanical trauma is an appealing assumption. However, is this assumption a true reflection of clinical practice? For example, the ability to visualize both the needle tip and relevant neural targets at all times is extremely difficult. In fact, data from Koff et al.  's own institution suggests that failure to maintain needle visualization during advancement may occur in up to 43% of novices (<10 ultrasound-guided blocks) and 10% of experienced providers (>60 ultrasound-guided blocks) performing ultrasound-guided techniques.14 This is not a criticism, but rather a reflection of the difficultly associated with maintaining needle alignment within the narrow plane (1 mm) of the ultrasound beam. Finally, preliminary evidence is beginning to suggest that ultrasound-guided technology may allow regional techniques to be performed with lower volumes of local anesthetic while maintaining similar degrees of block efficacy. This benefit may theoretically influence risk factors of neural injury associated with direct local anesthetic neurotoxicity. However, definitive data are currently lacking on these assumptions as well.
In summary, the case report by Koff et al.  highlights several important points. First, clinicians must identify all potential risk factors associated with perioperative nerve injury prior to performing regional techniques. This includes recognizing that patients with preexisting neurologic deficits may be particularly susceptible to secondary injuries. Second, consider whether the perceived benefits of regional anesthesia justify the potential for added risk (mechanical trauma, neural ischemia, local anesthetic toxicity). If so, consider modifying your anesthetic technique to minimize the impact of additional risk factors. Modifications may include reducing local anesthetic concentrations, eliminating epinephrine additives, or proceeding with general anesthesia. Finally, recognize the limitations of ultrasound-guided technology in reducing the risks associated with neurologic complications. Failure to appreciate the limitations of ultrasound may breed complacency and create an illusion of safety—factors that may increase  the risk of nerve injury and adverse patient outcomes.
Department of Anesthesiology, Mayo Clinic, Rochester, Minnesota.
Brull R, McCartney CJ, Chan VW, El-Beheiry H: Neurological complications after regional anesthesia: Contemporary estimates of risk. Anesth Analg 2007; 104:965–74Brull, R McCartney, CJ Chan, VW El-Beheiry, H
Moen V, Dahlgren N, Irestedt L: Severe neurological complications after central neuraxial blockades in Sweden 1990–1999. Anesthesiology 2004; 101:950–9Moen, V Dahlgren, N Irestedt, L
Koff MD, Cohen JA, McIntyre JJ, Carr CF, Sites BD: Severe brachial plexopathy after an ultrasound-guided single injection nerve block for total shoulder arthroplasty in a patient with multiple sclerosis. Anesthesiology 2008; 108:325–8Koff, MD Cohen, JA McIntyre, JJ Carr, CF Sites, BD
Cheney FW, Domino KB, Caplan RA, Posner KL: Nerve injury associated with anesthesia: A closed claims analysis. Anesthesiology 1999; 90:1062–9Cheney, FW Domino, KB Caplan, RA Posner, KL
Warner MA, Warner ME, Martin JT: Ulnar neuropathy: Incidence, outcome, and risk factors in sedated or anesthetized patients. Anesthesiology 1994; 81:1332–40Warner, MA Warner, ME Martin, JT
Urban MK, Urquhart B: Evaluation of brachial plexus anesthesia for upper extremity surgery. Reg Anesth 1994; 19:175–82Urban, MK Urquhart, B
Upton AR, McComas AJ: The double crush in nerve entrapment syndromes. Lancet 1973; 2:359–62Upton, AR McComas, AJ
Pogorzelski R, Baniukiewicz E, Drozdowski W: Subclinical lesions of peripheral nervous system in multiple sclerosis patients [in Polish]. Neurol Neurochir Pol 2004; 38:257–64Pogorzelski, R Baniukiewicz, E Drozdowski, W
Sarova-Pinhas I, Achiron A, Gilad R, Lampl Y: Peripheral neuropathy in multiple sclerosis: A clinical and electrophysiologic study. Acta Neurol Scand 1995; 91:234–8Sarova-Pinhas, I Achiron, A Gilad, R Lampl, Y
Horlocker TT, Kufner RP, Bishop AT, Maxson PM, Schroeder DR: The risk of persistent paresthesia is not increased with repeated axillary block. Anesth Analg 1999; 88:382–7Horlocker, TT Kufner, RP Bishop, AT Maxson, PM Schroeder, DR
Lynch NM, Cofield RH, Silbert PL, Hermann RC: Neurologic complications after total shoulder arthroplasty. J Shoulder Elbow Surg 1996; 5:53–61Lynch, NM Cofield, RH Silbert, PL Hermann, RC
Neal JM, Hebl JR, Gerancher JC, Hogan QH: Brachial plexus anesthesia: Essentials of our current understanding. Reg Anesth Pain Med 2002; 27:402–28Neal, JM Hebl, JR Gerancher, JC Hogan, QH
Horlocker TT, Wedel DJ: Ultrasound-guided regional anesthesia: In search of the holy grail. Anesth Analg 2007; 104:1009–11Horlocker, TT Wedel, DJ
Sites BD, Spence BC, Gallagher JD, Wiley CW, Bertrand ML, Blike GT: Characterizing novice behavior associated with learning ultrasound-guided peripheral regional anesthesia. Reg Anesth Pain Med 2007; 32:107–15Sites, BD Spence, BC Gallagher, JD Wiley, CW Bertrand, ML Blike, GT